TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 2 | -3 | -14 | 17 | -16 | -17 | -5 |
| P | %wins | 100 | 50 | 0 | 50 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/20 17:14 | 4/14/20 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | DO | CEO,P | P | 99 | 4.70 | 0 | 21 | New | 21 | D | ||||||||||||||
7/2/04 12:11 | 6/30/04 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | VP of Cl | P.d | 3 | 1.91 | 2 | 1 | New | 1 | D | -76 | -25 | -39 | -55 | 13 | -7 | -3 | -4 | 1 | -7 | -25 | -1 | 7 | 0 |
1/2/04 11:56 | 12/31/03 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | VP of Cl | P | 3 | 2.48 | 3 | 1 | 90 | 2 | D | -41 | -52 | 22 | 17 | 28 | 22 | 17 | 6 | 2 | 1 | -2 | 35 | -39 | -33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |